Pirazolac is a non‑steroidal anti‑inflammatory drug (NSAID) belonging to the heterocyclic acetic‑acid class, characterized by a pyrazole-acetic acid core structure. It is mainly utilized in research and pharmacological studies, not as an approved therapeutic drug in most markets. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include 4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazole-3-acetic acid and 4-Iodopyrazole. Its PubChem CID is 51222.
Pirazolac
| CAS No | 71002-09-0 |
|---|---|
| Molecular Formula | C17H12ClFN2O2 |
| Molecular Weight | 330.7 g/mol |
| Synonyms | 2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pirazolac is a non‑steroidal anti‑inflammatory drug (NSAID) belonging to the heterocyclic acetic‑acid class, characterized by a pyrazole-acetic acid core structure.
The listed CAS number is 71002-09-0.
The listed molecular formula is C17H12ClFN2O2.
The listed molecular weight is 330.7 g/mol.
2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic acid.
The source lists 4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazole-3-acetic acid and 4-Iodopyrazole.